Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.
Barrow
Su-yan L
SY
Melbourne Dental School, The University of Melbourne, Australia. barrows@unimelb.edu.au
D000368:Aged; D019386:Alendronate / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003827:Denture, Complete, Upper / Q000009:adverse effects; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000188:drug therapy; D019226:Oral Ulcer / Q000209:etiology; D010020:Osteonecrosis / Q000139:chemically induced* / Q000188:drug therapy; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010159:Palate / Q000187:drug effects*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate